Disruptive innovations in the clinical laboratory: catching the wave of precision diagnostics

Abstract

Disruptive innovation is an invention that disrupts an existing market and creates a new one by providing a different set of values, which ultimately overtakes the existing market. Typically, when disruptive innovations are introduced, their performance is initially less than existing standard technologies, but because of their ability to bring the cost down, and with gradual improvement, they end up replacing established service standards. Disruptive technologies have their fingerprints in health care. Pathology and laboratory medicine are fertile soils for disruptive innovations because they are heavily reliant on technology. Disruptive innovations have resulted in a revolution of our diagnostic ability and will take laboratory medicine to the next level of patient care. There are several examples of disruptive innovations in the clinical laboratory. Digitizing pathology practice is an example of disruptive technology, with many advantages and an extended scope of applications. Next-generation sequencing can be disruptive in two ways. The first is by replacing an array of laboratory tests, which each requires expensive and specialized instruments and expertise, with a single costeffective technology. The second is by disrupting the current paradigm of the clinical laboratory as a diagnostic service by taking it into a new era of preventive or primary care pathology. Other disruptive innovations include the use of dry chemistry reagents in chemistry analyzers and also point of care testing. The use of artificial intelligence is another promising disruptive innovation that can transform the future of pathology and laboratory medicine. Another emerging disruptive concept is the integration of two fields of medicine to create an interrelated discipline such as "histogenomics and radiohistomics." Another recent disruptive innovation in laboratory medicine is the use of social media in clinical practice, education, and publication. There are multiple reasons to encourage disruptive innovations in the clinical laboratory, including the escalating cost of health care, the need for better accessibility of diagnostic care, and the increased demand on the laboratory in the era of precision diagnostics. There are, however, a number of challenges that need to be overcome such as the significant resistance to disruptive innovations by current technology providers and governmental regulatory bodies. The hesitance from health care providers and insurance companies must also be addressed. Adoption of disruptive innovations requires a multifaceted approach that involves orchestrated solutions to key aspects of the process, including creating successful business models, multidisciplinary collaborations, and innovative accreditation and regulatory oversight. It also must be coupled with successful commercialization plans and modernization of health care structure. Fostering a culture of disruptive innovation requires establishing unique collaborative models between academia and industry. It also requires uncovering new sources of ...

Dynamics of Social Enterprises in Health Care Delivery: Contexts, Models, and Policy Insights From Malaysia

“…Although disruptive innovation is widely accepted as a main renewable force to combat inefficiency issues in health care, 19 our understanding in this context is mostly on literatures in the stream of socio-technical perspective derived from the cases of disruptive technology and equipment (e.g., mHealth, telemedicine, artificial intelligence, and cloud-based platform). 20,21 The perspective on business model, especially the SEs, deserves more focused research based on empirical fact findings. This study went beyond describing technologies as disruptive technological innovations, and attention is given to the business model innovation associated with the health care delivery service—SEs as an agent of disruptive innovation from the lens of community-driven initiatives.…”

inovação tecnológica e os desafios representados pela Inteligência Artificial

“…(POŠĆIĆ, 2020). Além das inovações técnicas, as inovações do modelo de negócios, bem como as inovações de produtos ou serviços (KHATAB, 2021;FACCIA, 2022), e a combinação de ambas levam as empresas ao ponto de captação de novos clientes e vendas exclusivas que só são possíveis por meio de novas tecnologias. (NIEWÖHNER, 2020).…”

Open Innovation as the Catalyst in the Personalized Medicine to Personalized Digital Medicine Transition

“…[1]. Although heterogeneous and multiple data have been generated through the years (from genomics to epigenetics), novel technologies have been developed to collect, analyze, and manage information from clinical and real-world scenarios, including artificial intelligence (AI)-based mathematical formalisms for data analysis or digital solutions for data capture [2].…”